SAN DIEGO, Jan. 03, 2019 /PRNewswire-PRWeb/ -- Triple W, an innovator of connected health devices, will feature DFree®, the first wearable device for incontinence, at the Consumer Electronics Show (CES), in Las Vegas, January 8-11. According to the U.S. National Institutes of Health, urinary incontinence affects 500 million people worldwide.
DFree uses ultrasound technology to monitor bladder fullness and notifies you on your smartphone or tablet when it's time to go to the bathroom. DFree helps to prevent accidental urinary leaks. Seniors and people with disability who need to manage a loss of bladder control now have an alternative to disposable diapers or pads and medications with the DFree wearable health device from Triple W. DFree stands for "diaper-free."
DFree was named a CES 2019 Innovation Award Honoree and recently received the Innovative HME (Home Medical Equipment) Retail Product Award. DFree is designed not only to help people with incontinence improve their quality of life and enable independence, but also to help reduce the burden for the caregivers.
To learn more about DFree, visit Triple W during CES at the following locations:
1). CES Unveiled Media Event, Sunday, Jan. 6, 2019 -- 5:00-8:30 pm
Mandalay Bay - Shorelines Exhibit Hall
2). ShowStoppers Media Event, Tuesday, Jan. 8, 2019 -- 6:00-10:00 pm
Wynn Hotel, Lafite Ballroom
About Triple W
Triple W empowers people with incontinence to live without worries. Triple W believes that having control of your senses is the key to independence and living life to the fullest. The company was founded in 2015 and has offices in Tokyo, Paris and San Diego. DFree's award-winning and patented technology is currently used in over 500 senior care facilities in Japan, Europe and the U.S. since 2017. For more information visit: http://www.dfreeus.biz
D FREE is a registered trademark of Triple W Japan K.K. in the U.S. and other countries.
*DFree is not a medical device and is not intended to be used in the diagnosis, prevention, or treatment of diseases or conditions.
SOURCE Triple W
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.